<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>Cyberounds Online CME</title>
	<link>http://www.cyberounds.com/</link>
	<description>The latest online CME activities from Cyberounds</description>
	<atom:link href="http://www.cyberounds.com/feed/rss.xml" rel="self" type="application/rss+xml" />


<item>
	<title>The Current Treatment of Lupus Nephritis</title>
	<link>http://www.cyberounds.com/cmecontent/art499.html</link>
	<description>Conference Objectives: 1)Discuss the prevalence, classes and morbidity of lupus nephritis2)Apply the current treatment options to induce a remission in lupus nephritis3)Apply the current treatment options to maintain a remission in lupus nephritis.</description>
	<guid>http://www.cyberounds.com/cmecontent/art499.html</guid>
	<pubDate>Tue, 31 Jan 2012 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Lung Cancer Chemoprevention</title>
	<link>http://www.cyberounds.com/cmecontent/art497.html</link>
	<description>Conference Objectives: 1)Upon completion of this Cyberounds&lt;sup&gt;®&lt;/sup&gt;, the participant should be able to:2)Describe the principles of chemoprevention, including primary, secondary, and tertiary.3)Provide the definition of a biomarker4)Describe the risk factors for lung cancer 5)List interventions agents that have proven to be effective in lung cancer chemoprevention6)Discuss the principles of personalized chemoprevention and how these concepts will be applied in lung cancer chemoprevention trials.</description>
	<guid>http://www.cyberounds.com/cmecontent/art497.html</guid>
	<pubDate>Tue, 03 Jan 2012 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Progestins and the Brain</title>
	<link>http://www.cyberounds.com/cmecontent/art496.html</link>
	<description>Conference Objectives: 1)Discuss the differential effects of progestins on the regenerative (neurogenic) capacity of the brain2)Discuss the contrasting effects on brain metabolism induced by progesterone and medroxyprogesterone3)Discuss the clinical implications of progestin regulation of brain regeneration, metabolism and white matter generation4)Apply their understanding of the effects of long-term exposure to progestins on brain function and the chronic use of hormone therapies and contraceptives.</description>
	<guid>http://www.cyberounds.com/cmecontent/art496.html</guid>
	<pubDate>Thu, 01 Dec 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Endometrial Cancer</title>
	<link>http://www.cyberounds.com/cmecontent/art495.html</link>
	<description>Conference Objectives: 1)Discuss the clinical presentation and disease characteristics of patients with endometrial cancer2)Apply the epidemiology and risk factors associated with the development of endometrial cancer to their patients3)Detail surgical and non-surgical treatment options available for the management of patients with endometrial cancer4)List the most common cancer susceptibility syndromes associated with endometrial cancer5)Apply information about outcome and prognosis to patients with endometrial cancer</description>
	<guid>http://www.cyberounds.com/cmecontent/art495.html</guid>
	<pubDate>Mon, 10 Oct 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Pressure Ulcers</title>
	<link>http://www.cyberounds.com/cmecontent/art486.html</link>
	<description>Conference Objectives: 1)Distinguish between pressure ulcers and other types of skin breakdown2)Discuss the risk factors and contributing etiologies for pressure ulcers3)Apply the major treatment and preventative options for pressure ulcers4)Manage the possible complications of pressure ulcers.</description>
	<guid>http://www.cyberounds.com/cmecontent/art486.html</guid>
	<pubDate>Mon, 05 Sep 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Exercise for the Older Patient</title>
	<link>http://www.cyberounds.com/cmecontent/art494.html</link>
	<description>Conference Objectives: 1)Discuss how exercise fits into the care of older patients as primary, secondary and tertiary prevention2)List the strength and limitations of current evidence supporting the role of exercise for specific medical conditions3)Screen patients' levels of physical activity and physical functioning using validated instruments4)Counsel patients regarding exercise based on the patient's readiness to become active.</description>
	<guid>http://www.cyberounds.com/cmecontent/art494.html</guid>
	<pubDate>Mon, 08 Aug 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Medical Confidentiality and Exceptions</title>
	<link>http://www.cyberounds.com/cmecontent/art493.html</link>
	<description>Conference Objectives: 1)Describe the ethical and legal bases for medical confidentiality2)Describe the current state statutory protections and exceptions3)Describe various disclosure obligations.</description>
	<guid>http://www.cyberounds.com/cmecontent/art493.html</guid>
	<pubDate>Tue, 12 Jul 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Pharmacological Therapy of Cardiac Arrhythmias:  Atrial Fibrillation, Current Treatment and Novel Agents</title>
	<link>http://www.cyberounds.com/cmecontent/art484.html</link>
	<description>Conference Objectives: 1)Discuss the extent of the clinical problem of atrial fibrillation2)Describe the mechanisms underlying the generation of the cardiac action potential, the ion channels and the factors involved in generating the excitation impulse3)Enumerate the leading ideas about the electrophysiological mechanisms underlying the development of atrial fibrillation4)Apply the currently available antiarrhythmic medications that are used as rhythm control agents to treat atrial fibrillation, and be able to categorize them via the Vaughan Williams antiarrhythmic classification system5)Discuss a few new agents that have just become available or will become available or are under development for atrial fibrillation and the strategies to limit the side effects of the currently available agents.</description>
	<guid>http://www.cyberounds.com/cmecontent/art484.html</guid>
	<pubDate>Mon, 06 Jun 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Update on Osteoporosis</title>
	<link>http://www.cyberounds.com/cmecontent/art488.html</link>
	<description>Conference Objectives: 1)Discuss the risk factors and multiple etiologies associated with osteoporosis2)Discuss the contributions of skeletal history, physical examination and laboratory studies in the evaluation of bone loss3)Apply the major treatment and preventive options for osteoporosis4)Utilize the approaches to management of fragility fracture.</description>
	<guid>http://www.cyberounds.com/cmecontent/art488.html</guid>
	<pubDate>Mon, 09 May 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Palindromic Rheumatism </title>
	<link>http://www.cyberounds.com/cmecontent/art491.html</link>
	<description>Conference Objectives: 1)Describe the clinical picture of palindromic rheumatism2)Distinguish palindromic rheumatism from other forms of acute monoarticular arthritis3)Apply the guidelines for the treatment of palindromic rheumatism.</description>
	<guid>http://www.cyberounds.com/cmecontent/art491.html</guid>
	<pubDate>Tue, 29 Mar 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Lessons In SLE Genetics</title>
	<link>http://www.cyberounds.com/cmecontent/art490.html</link>
	<description>Conference Objectives: 1)Describe how SLE has a genetic basis, and that it is polygenic.2)Recognize that both common gene polymorphisms and rare genetic variants can both contribute to SLE susceptibility including &lt;i&gt;HLA-MHC II&lt;/i&gt; and &lt;i&gt;III&lt;/i&gt;, &lt;i&gt;IRF5&lt;/i&gt;, &lt;i&gt;ITGAM&lt;/i&gt;, &lt;i&gt;TNFAIP3&lt;/i&gt;, &lt;i&gt;BANK1&lt;/i&gt;, &lt;i&gt;BLK&lt;/i&gt; and &lt;i&gt;FCGR2A/3A/3B&lt;/i&gt;.3)Discuss studies indicating that lupus genes might regulate three distinct checkpoints in disease development Ã¢â‚¬â€ adaptive immunity, innate immunity and end-organ inflammation.</description>
	<guid>http://www.cyberounds.com/cmecontent/art490.html</guid>
	<pubDate>Mon, 14 Mar 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Evaluation and Treatment of Polycystic Ovary Syndrome</title>
	<link>http://www.cyberounds.com/cmecontent/art489.html</link>
	<description>Conference Objectives: 1)Outline a metabolic evaluation for a woman with PCOS2)Prepare ovulation induction for an anovulatory PCOS patient wishing to conceive3)Describe a pubertal abnormality that can occur in PCOS adolescents4)Discuss the pregnancy-related consequences of PCOS on maternal-fetal health.</description>
	<guid>http://www.cyberounds.com/cmecontent/art489.html</guid>
	<pubDate>Mon, 21 Feb 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Diagnosis and Treatment of Kidney Cancer</title>
	<link>http://www.cyberounds.com/cmecontent/art487.html</link>
	<description>Conference Objectives: 1)List the common presentation(s) of kidney cancer, as well as research into novel diagnostic approaches;2)Apply the basic work-up of kidney cancer to patients who may have the disease;3)Discuss and apply the basic principles and drugs useful in treatment of localized and metastatic kidney cancer.</description>
	<guid>http://www.cyberounds.com/cmecontent/art487.html</guid>
	<pubDate>Mon, 31 Jan 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Sports Nutrition for an Adult Female Endurance Athlete</title>
	<link>http://www.cyberounds.com/cmecontent/art485.html</link>
	<description>Conference Objectives: 1)Provide general energy intake recommendations for optimizing health and fitness performance2)Assess appropriateness of body weight for optimizing health and fitness performance3)Discuss importance of adequate carbohydrate and protein intake for optimal fitness performance4)Discuss recommendations for adequacy of fluid intake and type of fluid for rehydration.</description>
	<guid>http://www.cyberounds.com/cmecontent/art485.html</guid>
	<pubDate>Mon, 10 Jan 2011 16:00:00 GMT </pubDate>
</item>


<item>
	<title>Lipoproteins and Apolipoproteins In The Brain</title>
	<link>http://www.cyberounds.com/cmecontent/art472.html</link>
	<description>Conference Objectives: 1)List basic differences between systemic and brain lipoprotein systems2)Describe the origins of apolipoproteins and lipoproteins in the brain3)Discuss physiological relevance of lipoprotein transfer and recycling in the brain 4)Apply their overview of the roles of specific apolipoproteins in the brain to physiological and pathophysiological processes.</description>
	<guid>http://www.cyberounds.com/cmecontent/art472.html</guid>
	<pubDate>Tue, 14 Dec 2010 16:00:00 GMT </pubDate>
</item>

</channel>
</rss>

